India's patent office issues draft guidelines for pharma biotech patents
Technology
India's patent office just dropped draft guidelines to make reviewing pharma and biotech patents clearer and more consistent.
Since India is a global hub for medicines, these changes could shape how new drugs and treatments get protected.
Patent guidelines set novelty ethics standards
The draft guidelines aim to standardize how patent officers review applications, using court-backed frameworks for fairness.
There's also extra focus on tricky areas like gene diagnostics, stem cells, and cloning of farm animals, covering both what counts as "new" and what's ethically okay.
Legal expert Mohit Singh says this will boost trust in the system and encourage more research investment in India's biopharma scene.